IL22 and lobular neoplasia: IL-22, produced by Th17 cells, γδ T cells, and ILC3s, contributes to SLE via STAT3 signaling, promoting SOCS3-mediated MMP-9 induction and podocyte nephrin loss, exacerbating LN progression (83).